Trial intelligence / Profile preview

PATH Pilot: Tranexamic Acid vs Prophylactic Platelet Transfusions in HSCT

NCT02650791Phase 3Completed

Sponsor
Ottawa Hospital Research Institute
Start
Oct 2016
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in hemorrhage, sponsored by Ottawa Hospital Research Institute. Started Oct 2016; status: completed.

02

Drugs

tranexamic acid
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT02650791.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02650791.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call